3B BlackBio Dx Limited

BSE: 3BBLACKBIO532067ISIN INE994E01018

Healthcare
Healthcare Service Provider
BSE Healthcare

Share price

₹1,330.25-3.40 (-0.25%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹1,750.00
52W low: ₹1,083.50
Off 52W high: -23.99%
1M return: -18.40%
3M return: +10.25%
6M return: +1.08%
1Y return: -1.52%
20D avg volume: 3,161
50 DMA: ₹1,435.38
200 DMA: ₹1,341.66

Key ratios Consolidated

Market cap: ₹1,142 Cr
Current price: ₹1,330.25
52W high / low: ₹1,750.00 / ₹1,083.50
Face value: ₹10.00
P/E: 20.29
P/B: 3.51
EPS (TTM): ₹65.56
Book value / share: ₹378.58
ROE: —
ROCE: 22.60%
Operating margin: —
Net margin: —
Debt / equity: 0.01
Net debt: ₹-35.20 Cr
Interest cover: 321.71
Dividend yield: 0.38%
Dividend / share (TTM): ₹5.00
Payout: 7.63%
Cash conversion cycle: 158.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	33.49	35.43	50.35	33.90	22.23	22.50	25.39	29.15	19.43	23.00	17.67	19.18
	6.14	10.15	5.59	5.51	4.32	4.94	3.01	3.44	3.69	4.19	2.63	2.75
	39.63	45.58	55.93	39.41	26.55	27.44	28.41	32.58	23.12	27.19	20.30	21.93
	26.41	30.94	29.09	19.79	10.69	14.90	10.61	13.28	8.77	13.46	9.14	11.66
	7.85	7.26	13.67	9.19	5.62	7.22	6.16	7.51	5.12	4.48	4.97	6.16
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	1.73	—	—
	8.55	9.36	8.21	4.63	1.77	1.91	1.71	2.08	1.62	1.61	1.58	1.87
	0.10	0.10	0.09	0.04	0.01	0.04	0.02	0.04	0.01	0.04	0.03	0.04
	1.34	3.89	0.38	0.58	0.28	0.28	0.27	0.27	0.27	0.30	0.32	0.24
	8.87	10.03	6.93	5.29	3.08	5.01	2.93	3.24	2.21	5.32	2.24	2.78
	13.22	14.65	26.84	19.62	15.86	12.54	17.80	19.31	14.36	13.73	11.15	10.26
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	13.22	14.65	26.84	19.62	15.86	12.54	17.80	19.31	14.36	13.73	11.15	10.26
	4.24	4.84	4.40	4.58	3.22	4.50	4.30	4.44	3.06	4.94	2.63	2.67
	8.98	9.80	22.44	15.04	12.64	8.04	13.49	14.86	11.30	8.79	8.52	7.59
	10.48	11.44	26.19	17.55	14.76	9.38	15.75	17.35	13.19	10.26	9.94	8.86
Key metrics
	14.66	18.64	27.31	20.24	16.15	12.86	18.09	19.62	14.64	14.07	11.50	10.54
	43.80%	52.60%	54.20%	59.70%	72.60%	57.20%	71.20%	67.30%	75.30%	61.20%	65.10%	55.00%
	26.80%	27.70%	44.60%	44.40%	56.90%	35.70%	53.10%	51.00%	58.20%	38.20%	48.20%	39.60%
	—	4.30%	—	6.20%	—	4.50%	—	—	—	—	—	—
	50.70%	57.50%	98.30%	16.30%	14.40%	-2.20%	43.70%	52.00%	—	—	—	—
	-29.00%	21.90%	66.30%	1.20%	11.90%	-8.50%	58.30%	95.80%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	153.17	141.92	96.47	74.12	61.84	80.65
	27.39	25.56	15.08	12.53	7.23	6.90
	180.55	167.48	111.55	86.66	69.06	87.55
	106.23	90.51	47.55	42.33	33.75	44.33
	37.97	35.74	26.01	19.81	18.01	30.67
	0.00	0.00	0.00	1.73	0.33	1.03
	30.75	23.96	7.32	6.50	5.03	3.56
	0.33	0.24	0.11	0.12	0.20	0.11
	6.19	5.13	1.09	1.06	0.86	0.67
	31.12	25.32	13.39	12.80	9.75	8.37
	74.33	76.97	64.00	44.33	35.31	43.22
	0.00	0.00	0.00	0.00	0.00	0.00
	74.33	76.97	64.00	44.33	35.31	43.22
	18.06	17.04	16.31	12.23	9.37	11.02
	56.26	59.93	47.69	32.10	25.94	32.20
	65.66	69.94	55.66	37.46	34.55	42.89
Key metrics
	80.85	82.34	65.20	45.51	36.37	44.00
	52.78%	58.00%	67.60%	61.40%	58.80%	54.60%
	36.73%	42.20%	49.40%	43.30%	41.90%	39.90%
	—	22.60%	23.10%	—	—	—
	54.30%	47.10%	30.20%	19.90%	-23.30%	—
	14.75%	25.70%	48.60%	23.70%	-19.40%	—
	—	26.97	42.46	—	—	—
	—	0.88	0.91	—	—	—
	—	0.01	0.00	—	—	—
	—	-35.20	-12.16	—	—	—
	—	158.3	163.8	—	—	—
Balance sheet
	—	378.00	295.72	—	—	—
	—	192.66	132.19	—	—	—
	—	38.31	12.47	—	—	—
	—	50.09	36.52	—	—	—
	—	18.38	8.74	—	—	—
	—	23.37	17.89	—	—	—
	—	27.60	7.22	—	—	—
	—	6.92	1.97	—	—	—
	—	36.55	18.59	—	—	—
	—	3.11	0.31	—	—	—
	—	0.00	0.00	—	—	—
	—	3.11	0.31	—	—	—
	—	331.64	271.00	—	—	—
Cash flow
	—	52.48	43.36	—	—	—
	—	-23.59	-33.85	—	—	—
	—	-0.52	-3.22	—	—	—
	—	25.51	0.90	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	22.95	24.63	24.38	27.91	20.36	23.02	23.43	26.57	17.51	21.99	16.96	18.57
	5.30	1.30	4.63	3.91	4.31	4.91	3.01	3.43	3.68	4.15	2.47	2.75
	28.25	25.93	29.01	31.82	24.67	27.93	26.44	30.00	21.18	26.13	19.42	21.31
	9.89	13.65	10.15	12.30	8.99	13.79	8.71	11.73	7.39	12.14	7.58	10.16
	4.93	5.79	5.63	6.83	5.20	6.82	5.70	7.26	4.97	5.52	4.12	6.09
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	1.83	2.26	1.68	2.16	1.49	1.66	1.45	1.81	1.29	1.41	1.23	1.42
	0.00	0.00	0.02	0.01	0.01	0.03	0.02	0.03	0.01	0.04	0.02	0.04
	0.23	0.29	0.22	0.21	0.21	0.20	0.22	0.22	0.22	0.27	0.20	0.22
	3.20	5.00	2.78	3.02	2.14	4.64	1.80	2.27	1.36	4.88	2.00	1.81
	18.35	12.29	18.86	19.52	15.68	14.14	17.73	18.27	13.79	14.00	11.85	11.15
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	18.35	12.29	18.86	19.52	15.68	14.14	17.73	18.27	13.79	14.00	11.85	11.15
	4.24	4.84	4.40	4.58	3.22	4.90	4.28	4.13	3.06	4.94	2.63	2.67
	14.11	7.45	14.46	14.94	12.46	9.24	13.45	14.14	10.73	9.06	9.21	8.48
	16.47	8.69	16.88	17.44	14.54	10.79	15.70	16.51	12.53	10.57	10.75	9.90
Key metrics
	18.58	12.58	19.10	19.74	15.90	14.37	17.97	18.52	14.02	14.31	12.07	11.41
	81.00%	51.10%	78.30%	70.70%	78.10%	62.40%	76.70%	69.70%	80.10%	65.10%	71.20%	61.40%
	61.50%	30.20%	59.30%	53.50%	61.20%	40.10%	57.40%	53.20%	61.30%	41.20%	54.30%	45.70%
	—	3.80%	—	6.40%	—	5.10%	—	—	—	—	—	—
	12.70%	7.00%	4.10%	5.00%	16.30%	4.70%	38.10%	43.10%	—	—	—	—
	13.20%	-19.40%	7.50%	5.70%	16.10%	2.00%	46.00%	66.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	99.87	97.28	90.53	70.72	12.00	15.52
	15.14	14.16	15.03	12.32	4.09	10.09
	115.01	111.44	105.56	83.04	16.09	25.62
	45.99	45.08	41.63	36.60	13.43	17.15
	23.18	23.45	24.76	19.81	8.20	10.02
	0.00	0.00	0.00	—	0.68	1.70
	7.93	7.58	6.21	5.14	1.84	1.58
	0.03	0.04	0.10	0.11	0.20	0.11
	0.95	0.94	0.86	0.87	0.30	0.29
	14.00	12.95	10.07	10.32	2.38	3.20
	69.02	66.36	63.93	46.45	2.65	8.46
	0.00	0.00	0.00	—	—	—
	69.02	66.36	63.93	46.45	2.65	8.46
	18.06	17.04	16.37	12.23	0.49	0.46
	50.96	49.32	47.56	34.21	2.16	8.01
	59.48	57.56	55.51	39.93	2.88	10.67
Key metrics
	70.00	67.34	64.89	47.43	3.15	8.86
	70.09%	69.20%	71.70%	67.10%	26.20%	57.10%
	51.03%	50.70%	52.50%	48.40%	18.00%	51.60%
	—	20.40%	23.00%	—	—	—
	6.95%	7.50%	28.00%	489.30%	-22.70%	—
	3.39%	3.70%	39.00%	1,483.80%	-73.00%	—
	—	42.82	43.77	—	—	—
	—	0.87	0.94	—	—	—
	—	0.00	0.00	—	—	—
	—	-16.80	-5.96	—	—	—
	—	181.8	168.2	—	—	—
Balance sheet
	—	350.37	297.12	—	—	—
	—	152.36	124.05	—	—	—
	—	16.80	6.27	—	—	—
	—	43.20	35.18	—	—	—
	—	6.57	8.14	—	—	—
	—	23.29	17.89	—	—	—
	—	6.80	6.37	—	—	—
	—	1.34	1.59	—	—	—
	—	24.66	18.21	—	—	—
	—	0.00	0.31	—	—	—
	—	0.00	0.00	—	—	—
	—	0.00	0.31	—	—	—
	—	319.02	272.79	—	—	—
Cash flow
	—	42.82	44.47	—	—	—
	—	-19.80	-33.64	—	—	—
	—	-6.55	-3.07	—	—	—
	—	0.00	0.70	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +100.89%
Sales CAGR 5Y: —
Profit CAGR 3Y: +183.70%
Profit CAGR 5Y: —
Sales YoY (TTM): +6.95%
Profit YoY (TTM): +3.39%

Consolidated

Sales CAGR 3Y: +31.90%
Sales CAGR 5Y: —
Profit CAGR 3Y: +32.20%
Profit CAGR 5Y: —
Sales YoY (TTM): +54.30%
Profit YoY (TTM): +14.75%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 40.96%

Quarter	September 2026	June 2026
Promoter %	40.96%	40.97%

Holder	Type	Holding	Previous	Change
MITHLA DUBEY	Promoter	12.35%	12.35%	0.00%
MITHLA LABORATORIES PRIVATE LIMITED	Promoter	9.56%	—	—
DHIRENDRA DUBEY	Promoter	8.45%	8.45%	0.00%
RASHI DAGA	Public	5.62%	5.62%	0.00%
PRATEEK GOEL	Public	5.14%	5.14%	0.00%
OWN INFRACON PRIVATE LIMITED	Public	4.30%	4.41%	-0.11%
NIKHIL KUBER DUBEY	Promoter	4.17%	4.17%	0.00%
MAJ NAVRAJ SINGH GREWAL	Public	2.65%	2.65%	0.00%
2B BLACKBIO S.L. SPAIN	Promoter	2.48%	2.48%	0.00%
RAM KUBER DHIRENDRA KUMAR	Promoter	2.27%	2.27%	0.00%
DALMUS PERFORMANCE FOCUS FUND	Public	2.14%	—	—
ARK GLOBAL EMERGING COMPANIES LP	Public	1.94%	1.94%	0.00%
INVESTOR EDUCATION AND PROTECTION FUND A	Public	1.23%	1.23%	0.00%
SHALU AGGARWAL	Public	1.06%	1.06%	0.00%
SANDEEP KAPADIA	Public	1.00%	1.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Dr. Lal Pathlabs Limited	34,056	2,028.95	57.92	25.70%	+16.71% TTM	+8.93% TTM	+28.73%
Vijaya Diagnostic Centre Limited	14,676	1,424.85	72.05	19.20%	+24.48% TTM	+33.96% TTM	+39.02%
Metropolis Healthcare Limited	12,075	582.05	53.57	15.70%	+19.84% TTM	+41.90% TTM	+14.58%
Thyrocare Technologies Limited	7,883	495.25	55.01	33.60%	+21.99% TTM	+13.16% TTM	+9.41%
Nephrocare Health Services Limited	6,242	620.75	48.72	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,735	333.10	49.46	14.70%	+23.32% TTM	+7.94% TTM	+2.54%
Krsnaa Diagnostics Limited	1,566	482.90	15.97	10.60%	+15.90% TTM	+16.02% TTM	-37.25%
3B BlackBio Dx Limited	1,142	1,330.25	20.29	22.60%	+54.30% TTM	+14.75% TTM	-1.52%
HEALTH X PLATFORM LIMITED	863	271.20	-33.11	—	+28.85% TTM	+82.45% TTM	-8.73%
ONE GLOBAL SERVICE PROVIDER LIMITED S	861	440.70	11.65	65.70%	+161.55% TTM	+178.28% TTM	+21.17%
Gaudium IVF and Women Health Limited	779	107.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited S	144	140.35	-318.98	2.90%	+14.50% TTM	-117.58% TTM	+132.68%
Choksi Laboratories Ltd. S	142	203.90	65.77	12.30%	+10.74% TTM	+44.00% TTM	+38.05%
STAR IMAGING AND PATH LAB LIMITED	120	68.90	—	22.60%	—	—	-51.78%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	86	57.00	—	11.20%	—	—	—
Sharma East India Hospitals And Res S	34	87.05	24.11	14.20%	+14.13% TTM	-9.85% TTM	-38.28%
BANDARAM PHARMA PACKTECH LIMITED	34	19.03	25.81	4.70%	+114.59% TTM	+454.17% TTM	-22.14%
N.G.Industries Ltd. S	34	100.00	17.39	6.30%	+2.18% TTM	-74.06% TTM	-23.28%
Deccan Health Care Limited	29	12.00	11.40	3.20%	-0.37% TTM	+145.63% TTM	-29.41%
Chennai Meenakshi Multispeciality Hospital Ltd. S	27	36.78	-32.26	-2.80%	+0.08% TTM	+6.59% TTM	-29.27%
SAMSRITA LABS LIMITED	27	11.93	-3.33	-73.40%	—	—	-43.35%
Tejnaksh Healthcare Limited	26	12.83	21.19	5.90%	-12.97% TTM	-33.15% TTM	-27.02%
Transgene Biotek Ltd.	17	2.57	-12.11	-0.50%	-14.81% TTM	-23.85% TTM	-28.21%
Dolphin Medical Services Ltd. S	11	7.11	59.25	0.60%	-1.25% TTM	+700.00% TTM	+246.83%
Looks Health Services Limited S	11	10.08	504.00	0.20%	-41.89% TTM	-57.14% TTM	+101.20%

Filings & corporate actions

Recent announcements

3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....4 Nov 2026 · Board Meeting / Board Meeting
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Re-appointment of director who retires by rotation and being eligible, offers for re-appointment30 Sep 2026 · Company Update / Change in Management
Scrutinizer''s Report and Voting report for 54th AGM30 Sep 2026 · AGM/EGM / AGM
Outcome of AGM29 Sep 2026 · AGM/EGM / AGM
Closure of Trading Window25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Special Window for Re-lodgement of Transfer Requests of Physical shares18 Sep 2026 · Company Update / Newspaper Publication
Analyst/Investor Meet- Outcome16 Sep 2026 · Company Update / Analyst / Investor Meet
Analyst/Investor Meet intimation11 Sep 2026 · Company Update / Analyst / Investor Meet
Analyst/ Investor Meet Outcome11 Sep 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication8 Sep 2026 · Company Update / Newspaper Publication
Letter to Shareholders7 Sep 2026 · Company Update / General
Annual General Meeting to be held on 29th September, 20267 Sep 2026 · AGM/EGM / AGM
Dividend updates7 Sep 2026 · AGM/EGM / AGM
Record date and date of book closure for the purpose of Dividend and AGM7 Sep 2026 · AGM/EGM / AGM
Reg 34 (1) Annual Report FY 2025-267 Sep 2026 · Others / Reg. 34 (1) Annual Report
Notice of Annual General Meeting to be held on 29th September, 20267 Sep 2026 · AGM/EGM / AGM
Analyst/Investor Meet Intimation5 Sep 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication5 Sep 2026 · Company Update / Newspaper Publication
Analyst/Investor Meet Outcome29 Aug 2026 · Company Update / Analyst / Investor Meet
Analyst/ Investor Meet Intimation25 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 202614 Aug 2026 · Company Update / Newspaper Publication
Investor''s Presentation13 Aug 2026 · Company Update / Investor Presentation
Unaudited Financial Results for the quarter ended 30th June, 202613 Aug 2026 · Result / Financial Results
Outcome of Board Meeting held on 13th August, 202613 Aug 2026 · Board Meeting / Outcome of Board Meeting
3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Unaudited Standalone and ....5 Aug 2026 · Board Meeting / Board Meeting
Intimation to the holders of physical securities to furnish KYC details9 Jul 2026 · Company Update / General
Special Window for Re-lodgement of Transfer Requests of physical shares6 Jul 2026 · Company Update / Newspaper Publication
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 20184 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window26 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Specimen of letter sent to shareholders whose shares are liable to be transferred to IEPF25 Jun 2026 · Company Update / General
Newspaper Publication for Transfer of Unclaimed Dividend/Equity Shares to IEPF Authority25 Jun 2026 · Company Update / Newspaper Publication
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhirendra Dubey25 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Disclosure under Regulation 29 (2) of SEBI (SAST) Regulations, 201125 Jun 2026 · Company Update / General
Transcript of Analysts/Investors Call pertaining to the Financial Results for the quarter and Financial Year ended March 31, 20263 Jun 2026 · Company Update / Analyst / Investor Meet
Audio Recording of Analysts/Investors Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31, 20261 Jun 2026 · Company Update / Analyst / Investor Meet
Submission of Newspaper Publication30 May 2026 · Company Update / Newspaper Publication
Dividend Update29 May 2026 · Corp Action / Dividend Updates
Investor''s Presentation29 May 2026 · Company Update / Investor Presentation
Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March, 202629 May 2026 · Result / Financial Results

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 5.0000	22 Sep 2026	22 Sep 2026	—
Dividend - Rs. - 4.0000	19 Sep 2025	19 Sep 2025	—
Final Dividend - Rs. - 3.0000	17 Sep 2024	—	—

Board meetings

13 Aug 2026 Board Meeting - Financial Results